The Lead Episode 144: A Discussion of Enhanced Detection and Prompt Diagnosis of Atrial Fibrillation Using Apple Watch: A Randomized Controlled Trial-The Lead Episode 144 Speaker Information

The Lead Episode 144 Speaker Information

Pdf Summary

This document introduces a hosted discussion of a research article titled “Enhanced Detection and Prompt Diagnosis of Atrial Fibrillation Using Apple Watch: A Randomized Controlled Trial,” published in the <em>Journal of the American Heart Association</em>. The session is hosted by Melissa E. Middeldorp (University of Adelaide), who presents the article for discussion.

Contributors to the discussion include Kristie Coleman (Lennox Hill Hospital) and Marco Perez (Stanford University). The document primarily provides event and participant information rather than study results, including author names for the featured trial: Nicole J. van Steijn, Isabel S. Blommestijn, Sebastiaan Blok, Shari Pepplinkhuizen, Aernout Somsen, Reinoud E. Knops, Laura Breukel, Jan G.P. Tijssen, Igor I. Tulevski, Philip M. Croon, and Michiel M. Winter.

It also lists disclosures: Middeldorp reports no conflicts but notes honoraria/speaking/teaching/consulting with Medtronic. Marco Perez reports honoraria/teaching/speaking/consulting with Boston Scientific and Biotronik, ownership/partnership in QALY, and research support from Apple, Inc. The document ends with a brief “Thank you” slide.

Keywords

atrial fibrillation

Apple Watch

randomized controlled trial

enhanced detection

prompt diagnosis

hosted research discussion

Journal of the American Heart Association

Melissa E. Middeldorp

Marco Perez

conflict of interest disclosures